Relationship between plasma cathepsin S and cystatin C levels and coronary plaque morphology of mild to moderate lesions: An in vivo study using intravascular ultrasound

Chinese Medical Journal

Volumn 122, Issue 23, 2009, Pages 2820-2826

  Gu, Fei Fei ^a,b   Lü, Shu Zheng ^a   Chen, Yun Dai ^c   Zhou, Yu Jie ^a   Song, Xian Tao ^a   Jin, Ze Ning ^a   Liu, Hong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CHINA MEITAN GENERAL HOSPITAL   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Atherosclerosis; Cathepsin S; Cystatin C; Intravascular ultrasound; Vulnerable plaque

Indexed keywords

CATHEPSIN S; CYSTATIN C;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; IN VIVO STUDY; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; AGED, 80 AND OVER; CATHEPSINS; CORONARY ARTERY DISEASE; CYSTATIN C; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 74549179030     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.23.004     Document Type: Article

References (27)

1. Adiguzel E, Ahmad PJ, Franco C, Bendeck MP. Collagens in the progression and complications of atherosclerosis. Vasc Med 2009; 14: 73-89.
2. Rodríguez JA, Orbe J, Páramo JA. Metalloproteases, vascular remodeling and atherothrombotic syndromes. Rev Esp Cardiol 2007; 60: 959-967.
3. Punturieri A, Filippov S, Allen E, Caras I, Murray R, Reddy V, et al. Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages. J Exp Med 2000; 192: 789-799.
4. Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998; 102: 576-583.
5. Rodgers KJ, Watkins DJ, Miller AL, Chan PY, Karanam S, Brissette WH, et al. Destabilizing role of cathepsin S in murine atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2006; 26: 851- 856.
6. Liu J, Sukhova GK, Sun JS, Xu WH, Libby P, Shi GP. Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24: 1359-1366.
7. Dubin G. Proteinaceous cysteine protease inhibitors. Cell Mol Life Sci 2005; 62: 653-669.
8. Shi GP, Sukhova GK, Grubb A, Ducharme A, Rhode LH, Lee RT, et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 1999; 104: 1191-1197.
9. von Birgelen C, Klinkhart W, Mintz GS, Papatheodorou A, Herrmann J, Baumgart D, et al. Plaque distribution and vascular remodeling of ruptured and nonruptured coronary plaques in the same vessel: an intravascular ultrasound study in vivo. J Am Coll Cardiol 2001; 37: 1864-1870.
10. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
11. Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, et al. Am College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001; 37: 1478-1492.
12. Finet G, Ohayon J, Rioufol G, Lefloch S, Tracqui P, Dubreuil O, et al. Morphological and biomechanical aspects of vulnerable coronary plaque. Arch Mal Coeur Vaiss 2007; 100: 547-553.
13. Takeuchi H, Morino Y, Matsukage T, Masuda N, Kawamura Y, Kasai S, et al. Impact of vascular remodeling on the coronary plaque compositions: an investigation with in vivo tissue characterization using integrated backscatter-intravascular ultrasound. Atherosclerosis 2009; 202: 476-482.
14. Higashikuni Y, Tanabe K, Yamamoto H, Aoki J, Nakazawa G, Onuma Y, et al. Relationship between coronary artery remodeling and plaque composition in culprit lesions: an intravascular ultrasound radiofrequency analysis. Circ J 2007; 71: 654-660.
15. Jormsjö S, Wuttge DM, Sirsjö A, Whatling C, Hamsten A, Stemme S, et al. Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 2002; 161: 939-945.
16. Lutgens SP, Cleutjens KB, Daemen MJ, Heeneman S. Cathepsin cysteine proteases in cardiovascular disease. FASEB J 2007; 21: 3029-3041.
17. Liu J, Ma L, Yang J, Ren A, Sun Z, Yan G, et al. Increased serum cathepsin S in patients with atherosclerosis and diabetes. Atherosclerosis 2006; 186: 411-419.
18. de Nooijer R, Bot I, von der Thüsen JH, Leeuwenburgh MA, Overkleeft HS, Kraaijeveld AO, et al. Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosis. Arterioscler Thromb Vasc Biol 2009; 29: 188-194.
19. Riese RJ, Mitchell RN, Villadangos JA, Shi GP, Palmer JT, Karp ER, et al. Cathepsin S activity regulates antigen presentation and immunity. J Clin Invest 1998; 101: 2351-2363.
20. Lindstedt L, Lee M, Öörni K, Bromme D, Kovanen PT. Cathepsins F and S block HDL3-induced cholesterol efflux from macrophage foam cells. Biochem Biophys Res Commun 2003; 312: 1019-1024.
21. Niccoli G, Conte M, Della Bona R, Altamura L, Siviglia M, Dato I, et al. Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate. Atherosclerosis 2008; 198: 373-380.
22. Koenig W, Twardella D, Brenner H, Rothenbacher D. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem 2005; 51: 321-327.
23. Jernberg T, Lindahl B, James S, Larsson A, Hansson LO, Wallentin L. Cystatin C: a novel predictor of outcome in suspected or confirmed non ST-elevation acute coronary syndrome. Circulation 2004; 110: 2342-2348.
24. Luc G, Bard JM, Lesueur C, Arveiler D, Evans A, Amouyel P, et al; PRIME Study Group. Plasma cystatin-C and development of coronary heart disease: The PRIME Study. Atherosclerosis 2006; 185: 375-380.
25. Virmani R, Burke AP, Kolodgie FD, FarbA. Pathology of thin-cap fibroatheroma: a type of vulnerable plaque. J Interv Cardiol 2003; 16: 267-272.
26. Kashiwagi M, Tanaka A, Kitabata H, Tsujioka H, Matsumoto H, Arita Y, et al. Relationship between coronary arterial remodeling, fibrous cap thickness and high-sensitivity C-reactive protein levels in patients with acute coronary syndrome. Circ J 2009; 73: 1291-1295.
27. Schoenhagen P, Ziada KM, Kapadia SR, Crowe TD, Nissen SE, Tuzcu EM. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study. Circulation 2000; 101: 598-603.